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Abstract
Adhesion molecules play important roles in airway hyperresponsiveness or airway inflammation. Our previous study
indicated catenin alpha-like 1 (CTNNAL1), an alpha-catenin-related protein, was downregulated in asthma patients and
animal model. In this study, we observed that the expression of CTNNAL1 was increased in lung tissue of the ozone-stressed
Balb/c mice model and in acute ozone stressed human bronchial epithelial cells (HBEC). In order to identify the possible
DNA-binding proteins regulating the transcription of CTNNAL1 gene in HBEC, we designed 8 oligo- nucleotide probes
corresponding to various regions of the CTNNAL1 promoter in electrophoretic mobility shift assays (EMSA). We detected 5
putative transcription factors binding sites within CTNNAL1 promoter region that can recruit LEF-1, AP-2a and CREB
respectively by EMSA and antibody supershift assay. Chromatin immunoprecipitation (ChIP) assay verified that AP-2 a and
LEF-1 could be recruited to the CTNNAL1 promoter. Therefore we further analyzed the functions of putative AP-2 and LEF-1
sites within CTNNAL1 promoter by site-directed mutagenesis of those sites within pGL3/FR/luc. We observed a reduction in
human CTNNAL1 promoter activity of mutants of both AP-2a and LEF-1 sites. Pre-treatment with ASOs targeting LEF-1and
AP-2a yielded significant reduction of ozone-stress-induced CTNNAL1 expression. The activation of AP-2a and LEF-1,
followed by CTNNAL1 expression, showed a correlation during a 16-hour time course. Our data suggest that a robust
transcriptional CTNNAL1 up-regulation occurs during acute ozone-induced stress and is mediated at least in part by ozone-
induced recruitments of LEF-1 and AP-2a to the human CTNNAL1 promoter.
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Introduction
Catenin alpha-like-1(CTNNAL1) was first characterized as a
2.45-kb transcript that was down-regulated in human pancreatic
cancer cells [1]. With 734 amino acids, the predicted CTNNAL1
polypeptide has similarities to human vinculin and a-catenin,
especially in the N-terminal region, which contains binding sites
for b-catenin, talin and a-actinin [2]. Amphipathic helices in the
C-terminal homology region corresponding to a-catenin contain
potential binding sites for the tight junction protein ZO-1 and the
actin cytoskeleton [2,3], suggesting that CTNNAL1 may act as a
cytoskeletal linker protein.
Recently, CTNNAL1 was identified as a part of the Rho
signalling pathway, serving as a scaffold protein for Lbc [3], a
member of the dbl family of Rho guanine nucleotide exchange
factors (GEFs) [4,5]. Rho GTPases play important roles during
organization of the actin cytoskeleton and formation of focal
adhesions [6]. Wiesner C et al [7] reported that CTNNAL1 also
interacts with the IkB kinase (IKK)- b, a key component of the
NF-kB signaling pathway. Ectopic expression of CTNNAL1
augmented NF-kB activity, promoted cell migration and increased
cell resistance to apoptosis.
In the previous study, we found that CTNNAL1 mRNA
decreased in the lung of OVA-sensitized asthma animal model.
There was a negative correlation between the pulmonary
resistance (RL) in asthma mice and the levels of CTNNAL1
mRNA in the 8-day time course after the OVA challenge. It is
conceivable that CTNNAL1 contributes to BEC constitutive
adhesion. In vitro experiments showed that the rate of repair and
proliferation of HBEC was slowed down after HBEC was treated
with CTNNAL1 ASO, and CTNNAL1 expression was explicitly
increased on the cells in wound edges. Those data indicate that
CTNNAL1 might be involved in growth regulation and may be
beneficial for the recovery of bronchial epithelium damage [8].
In an attempt to identify the response of CTNNAL1 to acute
stress, we observed the CTNNAL1 expression under an ozone
stressed condition. As shown in this study, CTNNAL1 mRNA was
increased both in lungs and in cultured HBEC with the acute
ozone stress.
Taken together, our results suggest that CTNNAL1 is involved
in maintaining the integrity of the airway epithelium and down
regulation of CTNNAL1 expression might contribute to epithelial
dysfunction and asthma development. CTNNAL1 upregulation
under acute stress conditions might be a protective response. The
next question is the mechanisms regarding the regulation of
CTNNAL1 expression in HBECs.
Although several studies have shown the significance of altered
CTNNAL1 expression, and the exon-intron organization and
boundary sequences flanking 19 exons of the human CTNNAL1
gene have been reported recently [2], the mechanism underlying
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yet. In order to explore the mechanisms of transcriptional
regulation of the CTNNAL1 gene, we identified some potential
DNA-binding proteins that can be recruited to CTNNAL1
promoter region and may play roles in the regulation of the
transcription of CTNNAL1 gene in this study. Our current
findings may help direct further research on the regulation and
function of CTNNAL1.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Ethics Committee Institute of
Clinical Pharmacology of the Central South University (Permit
Number: CTXY-090012). All surgery was performed under
sodium pentobarbital anesthesia, and all efforts were made to
minimize suffering.
Materials
LightShift Chemiluminescent EMSA Kit was purchased from
Pierce Biotechnology. Synthetic oligonucleotides were synthesized
by TaKaRa Inc (Dalian China). Anti-LEF-1, anti-AP-2a, anti-
CREB polyclonal antibodies and mouse IgG were purchased from
Santa Cruz Biotechnology. All chemicals were purchased from
Sigma unless stated otherwise.
Cells culture
The 16HBE14o
2cells, a generous gift of Dr. Dieter C Gruenert,
University of California San Francisco, were SV40-transformed
human central airway epithelial cells [9]. Cells were cultured in a
mixture medium of DMEM: F12 (1:1) (Sigma, St. Louis, MO)
containing 100 u/ml penicillin, 100 u/ml streptomycin, and 10%
fetal bovine serum (Hangzhou Sijiqing Biotech. Hangzhou, China)
and incubated at 37uCi n5 %C O 2.
Animal and cell model of ozone exposure
Balb/c mice were obtained from the experimental animal
center, Xiangya School of Medicine, Central South University. All
mice were housed under specific pathogen-free conditions and had
ad libitum access to food and water. The mice housed in whole-
body exposure chambers were exposed to ozone concentrations of
2 ppm for 30 min/day for 0,1,2,4,8 days respectively (n=6/
group), while they were awake and breathing spontaneously in the
chamber. Cells were exposed to 2 ppm ozone for 30 min under
culture conditions using the same equipment as the mice.
In situ hybridization (ISH) detection for CTNNAL1 mRNA
in cultured HBEC and lung tissue
The following probes labeled 5-end with digoxin (purchased
from TaKaRa Biotechnology Company) were used for ISH to
localize mouse CTNNAL1 mRNA: 59-ATCACCACACTTATA-
AACCATAAAGATAATACCAA-39,5 9-GCATACATGCAGAG-
AGACATTTCAGGTGACTGGC-39,5 9-ATGTCCAGGATGG-
CCTATTCTCTGTATTTATTTAC-39 or human CTNNAL1
mRNA:59-ACCTTCCGGAGAAGCCCCAGGAAGACATTA-39,
59-ATGGAAGGGGTCTGAGAAGAGATAAGGGCG-39,5 9-G-
ATCAAAACTCGCTCGGTGGAGCAGACGCT-39.B r i e f l y ,t h e
lung tissues were fixed in 4% paraformaldehyde, embeded in
paraffin, cut into 6 mm paraffin sections and placed on slides, the
coverglasses with HBEC on them were fixed in 4% paraformalde-
hyde. They were incubated with 30% H2O2 a n d5 %p e p s i ni nt u r n
a n dt h e nh y b r i d i z e da t4 2 uC overnight with labeled probes (2.0 g/
ml). After washing, the slides and coverglasses were sequentially
incubated with blocking buffer, biotin labeled rabbit-anti-digoxin
antibody, streptavidin biotin peroxidase complex (sABC) and biotin
labeled peroxidase, followed by rinsing with PBS after every step. The
peroxidant activity was visualized by the 3, 3-diaminobenzidine
tetrahydrochloride (DAB). The coverglasses was incubated with
either normal mouse serum instead of the mouse-anti-digoxin
antibody or in absence of the labeled probe for the negative control.
Ozone stress in vitro and flow cytometry
16HBE14O-cells cells was stressed with ozone (1.5 ppm) for
30 min. Then, cells were harvested and washed twice in PBS 12 h
after ozone stress. After treated by 1% triton X-100 (Sigma) for
15 min, cells (1610
5 cells for each sample) were washed and
binded with mouse monoclonal to CTNNAL1 (ab57875, 1:250
dilution; Abcam, Cambridge, UK). Then, a phycoerythrin (PE)
fluorescence second antibody was used to label CTNNAL1
expression by flow cytometry. For all experiments, mean
fluorescence intensity (MFI) values were calculated by subtracting
primary antibody.
ASO design
Two ASOs were designed according to mRNA sequences of
AP-2a (59-CAGCTGGGGCAACCGTGCCGT-39 against nucle-
otides 55–72) and LEF-1 (59- TCCTCCGGAGAGTTGGGG-
CAT -39 against nucleotides 1–21). The sequence of the nonsense
oligonucleotide was 59- GGGGCCCACGGGCAGATCCAT -39.
All ASOs were verified by BLAST and were synthesized (by
TaKaRa) as 21-base phosphorothioate oligonucleotides. HBECs
were transfected with an ASO and Lipofectin (Invitrogen) mixture
for 4 h in serum-free DMEM, and then cultured in normal growth
media for 40 h. The effects of the ASOs were measured by real-
time PCR after ozone exposure for 30 min and further culture for
4h .
Real time PCR measurement
RNA was extracted from mouse lung tissues and cultured
HBEC and reverse transcription was performed by AMV reverse
transcriptase (QIAGEN, Gemany). PCR was then carried out
using ShineSybrH Real Time qPCR Kits (Shinegene, China).
ShineSybr is a 26convenient premix reagent, specially designed
for real time PCR by using sybr green I. This product combines
the high performance of Taq, which is an enzyme for hot start
PCR utilizing Taq antibody, with a newly developed buffer which
provides superior specificity, increased amplification efficiency and
high aptitude for high-speed real time PCR. The primers were
synthesized as Table 1. Briefly, 2 ml of the reverse-transcripts was
added to a 25 ml PCR mixture for 40 cycles. Each cycle included
93uC for 30 s, 60uC for 30 s and 72uC for 30 s. Normalization of
mRNA expression data for sample-to-sample variability in RNA
input, RNA quality, and reverse transcription efficiency was
achieved by comparing the copy numbers of target mRNAs with
that of mouse or human actin or mouse GAPDH for each run.
Nuclear protein extraction and electrophoretic mobility
shift assay (EMSA)
Nuclear extracts of HBEC were prepared as previously
described [10]. Nuclear extract protein concentrations were
determined using the Bradford protein assay (Bio-Rad Laborato-
ries, Inc., Hercules, CA). Gel shift assays were performed as
described previously [10].
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according to a computer-based search with the software Promoter
Scan (PROSCAN Version 1.7 suite of programs developed by Dr.
Dan Prestridge) and Transfac [11]encompassing putative binding
sites in the CTNNAL1 promoter.
EMSA was performed using LightShift Chemiluminescent
EMSA Kit according to the manufacture’s protocol. Nuclear
extracts (10 mg protein) were incubated with 1 mg poly[d(I-C)],
the binding buffer attached to the kit, and biotin end-labeled
oligonucleotide probe for 15 min at room temperature. Bound
DNA complexes were separated on a 5% nondenaturing
polyacrylamide gel electrophoresis and transferred to a positive
nylon membrane. The nylon membranes were UV cross-linked,
probed with streptavidin-HRP conjugate and incubated with the
chemiluminescent substrate for chemiluminescent detection. For
competition experiments, unlabelled competitor oligonucleotides
were pre-incubated at 100-fold excess with the labeled probe. The
nuclear factors in the retarded bands were verified using the assay
of mutated probes binding with extracts and antibody supershift
analysis.
Chromatin immunoprecipitation (ChIP)
To crosslink proteins to DNA, formaldehyde (final concen-
tration 1%) was added to the culture medium and incubated for
10 min at room temperature. Then, a final concentration of
Table 1. Oligonucleotide primers used for real-time PCR
analysis.
Sequence of primers
hCTNNAL1F 59-GGAGTTTGCACATCTGAGTGGA-39
hCTNNAL1R 59-CCAATGCCACTTTCATACGG-39
hLEF-1F 59-CACCCATCCCGAGAACATCA-39
hLEF-1R 59-GACATGCCTTGTTTGGAGTTGA-39
hAP-2aF5 9-GTGTCCCTGTCCAAGTCCAAC-39
hAP-2aR5 9-GACACTCGGGTGGTGAGAGC-39
h actin F 59-TGACGTGGACATCCGCAAAG-39
h actin R 59-CTGGAAGGTGGACAGCGAGG-3
mCTNNAL1F 59- TCTTCGGGAGAATGTTTGCTT-39
mCTNNAL1R 59- TGTGCTCGTGGCTGGTGTAG-39
mGAPDH F 59- TGTGTCCGTCGTGGATCTGA-39
mGAPDH R 59- CCTGCTTCACCACCTTCTTGA-39
doi:10.1371/journal.pone.0031158.t001
Figure 1. Expression of CTNNAL1 mRNA in ozone stressed mouse lung. (A) It was shown by in situ hybridization that the structure of lung
tissues was damaged after being stressed with ozone. Goblet cell hyperplasia and bronchial epithelial denudation were seen in the 2
nd and 4
th day of
ozone stress. The expression of CTNNAL1 mRNA was increased with the ozone stress (6200, bar=100 mm). Arrows indicate airway epithelium
damage. (B) Real time PCR showed the time course of CTNNAL1 expression in mice lung tissue. The result showed that the expression of CTNNAL1
mRNA was increased with the ozone stress, peaked on the 2nd day, and then decreased. (n=5, *P,0.05).
doi:10.1371/journal.pone.0031158.g001
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and collected. Cells were lysed with SDS lysis buffer (1% SDS,
10 mM EDTA, and 50 mM Tris, pH 8.1) containing protease
inhibitors. Aliquots of cell lysates were sonicated to shear DNA into
0.2–1.0 kb-fragments and cellular debris was removed. Chromatin
aliquots were precleared with 10 mg of mouse IgG bound to Protein
A-Sepharose (GE Healthcare). Samples were then incubated with
1 mg of specific antibodies overnight at 4uC with rotation.
Immunocomplexes were mixed with Protein A-Sepharose followed
by incubation for 1 h at 4uC with rotation. Beads were collected by
brief centrifugation and the immunocomplexes were eluted by
freshly prepared elution buffer (100 mM NaHCO3, 1% SDS).
Chromatin was then de-crosslinked for 5 h at 65uC. After treated
with proteinase K, DNA was phenol/chloroform-extracted, and
ethanol-precipitated. An aliquot (2 ml) of each sample was subjected
to PCR analysis [12].
Reporter gene construct and reporter gene assay
The putative promoter of the human CTNNAL1 gene was
PCR amplified (2569,2143 from ATG) and cloned into the
Kpn I and Bgl II site of the pGL3-basic luciferase reporter vector
(Promega; Madison, WI). This reporter was designated as wild-
type CTNNAL1-Luc (Wt- CTNNAL1-Luc) in this study.
Nucleotide identity and direction of the insert were verified by
sequencing of both strands. Various types of mutations were
introduced into Wt- CTNNAL1-Luc using genomic DNA
synthesis methods.
Transcription Element Search System (TESS) software was
used to analyze all possible binding sites of selected transcription
factor on the positive and negative chain of CTNNAL1promoter,
and to ensure none of the site-directed mutagenesis of transcrip-
tion factor binding sites would surplus create new binding sites of
other transcription factors.
Cells were seeded onto 24-well culture plates the day before
transfection. On the day of transfection, each reporter vector
(0.6 mg/well) was transfected into the cells using Lipofectamine
2000 reagent (Invitrogen) according to the manufacture’s protocol.
For standardization, the phRL-TK vector (Promega) (0.1 mg/well)
was also transfected into the cells. Six hours after transfection, the
medium was replaced and ozone treatment was added. Twenty-
four hours after the addition of the test agents, cells were harvested
by Passive Lysis Buffer (Promega), and reporter gene assay was
performed with Varioskan Flash multitechnology microplate
reader (Thermo Scientific) using Dual-luciferase assay system
(Promega). The results represent the average of three independent
transfection assays normalized to Renilla reniformis activity.
Statistical analyses
Data are presented as the mean 6 SEM from at least three
independent experiments. Statistical difference between two
groups was determined by t -test. Multiple comparisons were
performed by one-way ANOVA or repeated measures ANOVA
together with post-hoc pairwise comparisons. P,0.05 was
considered statistically significant.
Figure 2. The expression of CTNNAL1 on cultured human BEC was increased significantly after ozone stress. (A) CTNNAL1mRNA
expression on BEC assayed by in situ hybridization (DAB staining, 6200). (B) CTNNAL1mRNA expression on BEC assayed by real time PCR (n=4,
*P,0.05). (C) CTNNAL1 protein expression on BEC assayed by flow cytometry detection.
doi:10.1371/journal.pone.0031158.g002
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The expression of CTNNAL1 in lungs and cultured HBEC
Balb/c mice undergoing 0–8 day’s intermittent ozone stress
(2 ppm ozone for 30 min/day in whole-body exposure chambers)
showed an up-regulation of CTNNAL1 mRNA expression. It was
shown that the structure of lung tissues was damaged after being
stressed with ozone. Goblet cell hyperplasia and bronchial
epithelial denudation were seen in the 2nd and 4th day of ozone
stress. In situ hybridization and real-time PCR showed that
CTNNAL1 mRNA was increased with the ozone stress, peaked on
the second day, and then decreased slightly (Figure 1). In cultured
HBEC, after an acute 30 min ozone stress, the expression of
CTNNAL1 mRNA was explicitly increased (Figure 2A, B). We
also detect CTNNAL1 protein by flow cytometry. The results
showed that expression of CTNNAL1 protein was increased after
ozone stress (mean fluorescence intensity values 2.18%60.39% vs
3.58%60.91%, P,0.05, n=3, Figure 2C). These results revealed
that the expression of CTNNAL1 can respond to ozone stress.
Identification of transcription factors binding to the
human CTNNAL1 promoter region
Analysis with Promoter Scan (PROSCAN Version 1.7 suite of
programs developed by Dr. Dan Prestridge) and Transfac [11] on
CTNNAL1 gene 59 non-coding region suggesting that the host
range of promoter is 2552,2152 from ATG. In an attempt to
identify transcription factors that interact with this region, 8
synthetic DNA probes, designated probe 1–8 (50 bp each, covered
the full length of the promoter sequence), were subjected to gel
retardation assays (Figure 3A).
The binding reaction of probes with transcriptional factors were
observed using EMSA. It was shown that probe 1, 2, 3, 5, and 8
had significant retarded bands (Figure 3B). Competition with 100-
fold excess of unlabelled probes revealed specifically DNA–protein
binding of these 5 probes (Figure 3C).
The above gel retardation analyses suggest that multiple
proteins bind to separate sites on the promoter. Therefore we
analyzed further the nature of protein binding to these genomic
DNA sequences represented in probes 1, 2, 3, 5, and 8 by
introducing specific mutations followed by EMSA. was used to
analyze the putative nuclear transcription factor binding sites of
each probe [13].
A database search by Transcription Element Search System
(TESS) software of the promoter region revealed the presence of
several putative binding sites for transcription factors, including
AP1and LEF-1 on probe1; LEF-1 and C/EBPbeta on probe2; AP-
2 on probe3, CAC-binding_protein and LBP-1on probe5; CAC-
binding_protein and CREB on probe8, as shown in Figure 3A.
Mutation probes were designed accordingly (Figure 3A) and these
mutant probes were unlabelled and 100-fold excess used to
competent with the corresponding normal labeled probe. If the
mutation is valid, specific binding bands would not be competed
out; retarded bands can still be seen. If the mutation is invalid,
then the competition can be normal, with the loss of specific
bands. Results showed that the valid mutations were 1.2, 2.1
(representing the LEF-1 site), 3.1 (representing the AP-2 site) and
8.2 (representing the CREB site).
In super shift experiments with specific antibodies against those
transcription factors identified in EMSA and mutational analysis,
the three DNA-binding proteins were characterized independently
as LEF-1, AP-2a and CREB, as demonstrated by super shifted
specific DNA–protein complexes (Figure 4).
Next, we investigated whether these three nuclear factors could,
‘‘in vivo’’, physically bind the human CTNNAL1 promoter. The
binding of transcription factors to the CTNNAL1 promoter with
or without ozone stress was verified by chromatin immunopre-
cipitation (ChIP) assays (Figure 5). HBECs were exposed to
formaldehyde to cross-link proteins and DNA, and were sonicated
to fragment the chromatin. Specific antibody against LEF-1, AP-
2a, CREB or normal rabbit IgG were used to immunoprecipitate
the protein-DNA complexes. After immunoprecipitation, DNA
was extracted from the beads and used as a template to generate
specific PCR products. The presence of the promoter specific
DNA region before immunoprecipitation was confirmed by PCR
(input). PCR product was observed in LEF-1 and AP-2a
immunoprecipitation groups but not observed in CREB immu-
noprecipitation group, which indicating an interaction between
LEF-1 or AP-2a and CTNNAL1.
Figure 4. Supershift analyses were performed using nuclear
proteins from HBEC that were incubated with specific anti-
bodies against LEF-1, AP-2a, and CREB. The supershifted complex
detected with each antibody was indicated by ‘‘m’’. Note that each of
the LEF-1, AP-2a, and CREB antibodies caused a marked decrease in the
intensity of the complex (marked by ‘‘N’’) formed by the interaction of
antibody and nuclear extract.
doi:10.1371/journal.pone.0031158.g004
Figure 3. Screen of transcription factors binding to the human CTNNAL1 promoter region. (A) Depicted is the 400 bp DNA sequence of
the human CTNNAL1 promoter (2552,2152 from ATG) which was divided equally to probes 1–8 used for EMSA. Underlines represent possible
nuclear-factor-binding sites in corresponding probes. The shaded residues represent the mutated sites in different mutated probes. (B) DNA-protein
complexes binding to the human CTNNAL1 promoter were demonstrated in probes 1, 2, 3, 5, and 8. (C) EMSA competiton test of probe 1, 2, 3, 5, and
8. Competition with unlabeled primer significantly reduced the entire five probe’s binding intensity. (D) The nuclear factors in the retarded bands
were verified using the assay of mutated probes binding with extracts. 9 mutations according to putative binding sites search by TESS were designed
as shown in Figure 3A. The valid mutations (specific binding bands was be competed out by unlabelled and 100-fold excess mutation probes) were
1.2, 2.1 (representing the LEF-1 site), 3.1 (representing the AP-2 site) and 8.2 (representing the CREB site).
doi:10.1371/journal.pone.0031158.g003
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To further confirm whether LEF-1 and AP-2a can activate
transcription of CTNNAL1, CTNNAL1 promoter gene was inserted
into luciferase reporter plasmid pGL3-Basic to construct the human
CTNNAL1 promoter–luciferase reporter pGL3/CTNNAL1/luc.
TESS software was used to analyze all possible binding sites of
LEF-1 and AP-2a in positive and negative chain of CTNNAL1
promoter and found that LEF-1 had 5 possible binding sites, while
the AP-2a had 7 possible binding sites (Table 2). These multi-copy
loci indicate both LEF-1 and AP-2a might have important roles in
the regulation of transcription of CTNNAL1. We mutated all the
possible binding sites of LEF-1 or AP-2a on the luciferase reporter
plasmid containing the CTNNAL1 promoter.
The above plasmids were transiently transfected into human
bronchial epithelial cells. cells were then collected 48 h after
transfection to determine luciferase chemiluminescence signal
strength (RLU, relative chemiluminescence intensity). As shown in
Figure 6, transient transfection with the luciferase reporter 426 bp
(2569,2143 from ATG) luc-construct resulted in an increase in
luciferase activity relative to the empty promoter less pGL3-basic
vector, demonstrating that this DNA fragment contains significant
promoter activity in HBEC (5–10 fold increase). Results from
similar transfection experiment under ozone-stressed conditions
demonstrated a boost activation of the human CTNNAL1
promoter. After LEF-1 binding site mutation, RLU in normal
cells and ozone stressed group decreased 28.3% and 42.1%
respectively; after AP-2a binding site mutation, RLU in normal
cells and ozone stressed group were reduced 41.7% and 61.1%
respectively (Figure 6). These results suggest that, LEF-1 and AP-
2a binding sites were required for the maintenance of CTNNAL1
promoter activity, this effect is more pronounced under ozone
stress.
Regulation of LEF-1 and AP-2a on CTNNAL1 expression
in ozone stressed HBEC
To investigate whether LEF-1 and AP-2a were involved in the
CTNNAL1 mRNA up-regulation in ozone stressed HBEC, ASOs
targeting these two transcription factors were designed, and
treatment efficiency was assessed by real-time PCR. The results
showed that both ASOs caused substantial reduction in mRNA
expression levels in normal and ozone-stressed HBEC, while the
nonsense oligonucleotide had no effect (Figure 7A, B). CTNNAL1
mRNA expression was significantly up-regulated in ozone-stressed
BEC (Figure 7C), whereas pre-treatment with ASOs targeting
LEF-1and AP-2a yielded significant reduction of ozone-stress-
induced CTNNAL1 expression. Human CTNNAL1expression
under resting conditions could also affected by pre-treatment with
ASOs, with the lower degree than that of ozone-stressed HBEC,
(Figure 7C).
Table 2. Site-directed mutation position of two nuclear
factors.
Sequences
LEF-1 59- CCCCTC CCAT (2529 bp ART) CAGACTTGAT CAGC T (2486
ART)CAGCTTCC
39-GGGGAG GGTA (2529 bp TRA) GTCTGAACTAGTCG A (2486
TRA)GTCGAAGG
AGAAGTCTT A (2468TRA)GCGGAGGACGGGAAGCTT A(2412 TRA)
GCTGGG
TCTTCAGAA T (2468ART)CGCCTCC T GCCCTTCGAA T (2412 ART)
CGACCC
GACGCAGGCCATGTGGCTG A (2366 TRA)GTACAGATGTGTTT-39
CTGCGTCCGG TACACCGAC T (2366 ART) CATGTCTACACAAA-5
AP-2a 59-TCC T (2549 CRT)AGGGGAAAGGCC T (2536
CRT)CTCCCAAGAAGCTTTGCT
39-AGG A (2549 GRA)TCCCCTTTCCGG A (2536
GRA)GAGGGTTCTTCGAAACGA
A(2408 GRA)GGGACGCTTGTAAGAGATAAGGGC T(2280 GRT) GGGCC
ATG
T (2408 CRT)CCCTGCGAACA TT CTCT ATTCCCG A (2280 CRA)
CCCGGTAC
CTTAGGGGGTG T(2244 GRT)GGTTGCAGGGAGGCCGG T (2191
GRT)GGT G T
GAATCCCCCAC A (2244 CRA)CCAACGTCCC TCCGGCC A (2191
CRA)CCAC A
(2186 GRT)GCGGGGACA-39
(2186 CRA)CGCCCCTGT-59
doi:10.1371/journal.pone.0031158.t002
Figure 5. ChIP of three nuclear factors bound to the human CTNNAL1 gene. Cross-linked chromatin prepared from resting BEC or ozone-
stressed BEC was immunoprecipitated with three kinds of specific antibodies respectively, or nonimmune IgG as indicated.
doi:10.1371/journal.pone.0031158.g005
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ozone stressed HBEC
To further delineate the potential role of LEF-1 and AP-2a in
CTNNAL1 regulation in HBEC, a 16 h time course of LEF-1 and
AP-2a DNA-binding activity and CTNNAL1 expression was
examined after 30 min of ozone stress using EMSA (with probes 1
and 3 respectively) and real-time PCR respectively. The results
showed that the activation of LEF-1 occurred within 30 min and
peaked at 1 h after ozone exposure. The activation of AP-2a
occurred within 1 h of ozone exposure, peaked at 30 min and
decreased at 4 h.
CTNNAL1 mRNA expression as measured by real-time PCR
followed the pattern of LEF-1 and AP-2a activation. A gradual
increase of human CTNNAL1 expression occurred until it
reached the peak at 1 h, and then decreased (Figure 8 A, B).
Discussion
Transcription factors tightly regulate gene expression in
response to intra- and extracellular stimuli, and they often play a
central role in determining cell fate by controlling the fundamental
mechanism of gene transcription. In order to elucidate the
mechanism responsible for CTNNAL1 gene expression, we
designed a protocol in the present study to identify the putative
DNA-binding proteins regulating the transcription of CTNNAL1
gene. First, we speculated the putative promoter using a computer-
based search with the software Promoter Scan (PROSCAN
Version 1.7) and Transfac, by which a 400 bp DNA fragment
(2552,2152 from ATG) was determined to be the promoter
region. Next, 8 oligonucleotide probes, 50 bp each, were designed,
covering the overall promoter region. The spectrum of potential
nuclear factors involved in expression of CTNNAL1 was screened
using EMSA. On the basis of the assay of mutated probes and
antibody supershift, they were verified as LEF-1, AP-2a and
CREB. Then ChIP assay was used to verify the in vivo interaction
between these transcription factors and CTNNAL1 promoter.
Only AP-2a and LEF-1 show the binding on CTNNAL1
promoter. By site-directed mutagenesis of putative transcription-
factor-binding sites within pGL3/FR/luc, we observed a reduc-
tion in human CTNNAL1 promoter activity of mutants of both
AP-2a and LEF-1 sites. The time courses showed that ozone stress
can activate the AP-2a and LEF-1 within one hour. Ozone-
inducible CTNNAL1 expression correlated with AP-2a and LEF-
1 binding activity during a-16 hour time course. Furthermore, we
investigated if LEF-1 and AP-2a were involved in the mRNA
overexpression of the CTNNAL1 gene in ozone stressed HBEC.
ASOs targeting the two transcription factors were transfected into
the HBEC, and significant reduction of ozone-stress-induced
CTNNAL1 expression were observed by pre-treatment with these
two ASOs. Our data suggest that a robust transcriptional
CTNNAL1 up-regulation occurs during acute ozone-induced
stress and is mediated at least in part by ozone-induced
recruitment of LEF-1 and AP-2a to the human CTNNAL1
promoter.
Lymphoid Enhancer binding Factor-1 (LEF-1) is a nuclear
high mobility group (HMG) protein that mediates gene
transcription in response to canonical Wnt/beta-catenin signaling
pathway [14,15]. LEF-1 protein is expressed in a variety of
organisms and its expression and functional abnormalities can
lead to abnormal development of the organisms. Wnt signaling is
involved in virtually every aspect of embryonic development and
also controls homeostatic self-renewal in a number of adult
tissues. Germline mutations in the Wnt pathway cause several
hereditary diseases, and somatic mutations are associated with
cancer of the intestine and a variety of other tissues [15]. LEF-1
acts as a central transcription mediator of Wnt signaling,
regulating cell cycle and growth-relevant genes like Cyclin D1
and c-myc [16–18].
Figure 6. Effects of site-directed mutation in transcriptional factors LEF-1 and AP-2a on transcriptional activation of the human
CTNNAL1 luciferase reporter. Shown is transcriptional activation of the human CTNNAL1 luciferase reporter in BEC. Data represent the means of
relative luciferase activities (normalized to Renilla reniformis) from at least 5 independent transient transfection experiments each performed in
triplicate. (
*P,0.05 versus pGL3/CTNNAL1 under resting condition;
#P,0.05 versus pGL3/CTNNAL1 under ozone-stressed condition).
doi:10.1371/journal.pone.0031158.g006
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PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e31158Merdek KD et al reported a-catenin and CTNNAL1 had
distinct activities that down regulate b-catenin and Ras signals,
respectively, on the cyclin D1 promoter [3]. Our finding that LEF-
1, a b-catenin associated nuclear transcription factor, had the
effect to regulate CTNNAL1 expression, provided a clue for an
interaction between CTNNAL1 and b-catenin signaling pathway.
Interestingly, the sub-cellular localization showed expression of a-
catenin in the cell membrane, while the CTNNAL1 and b-catenin
both in cytoplasm and nucleus [19], which might provide some
support for the speculation.
AP-2a is a homodimeric 100 kDa transcription factor with a
core recognition element sequence of 59-GCCNNNGGC-39
[20,21]. AP-2a mediates transcriptional activation in response to
two signal transduction pathways: the phorbol ester/diacylgly-
cerol-inducible protein kinase C pathway and the cAMP-
dependent protein kinase A pathway [22]. Befitting a role of
Figure 8. Time course of human CTNNAL1 mRNA expression and DNA-protein binding activities of AP-2a and LEF-1. (A) The time
course of AP-2a and LEF-1 DNA binding to CTNNAL1 promoter sequence under ozone stress was determined by EMSA. Expression of human
CTNNAL1 mRNA was assayed by real-time PCR. Data represent means 6 SD of 4 independent experiments.
doi:10.1371/journal.pone.0031158.g008
Figure 7. Inhibition of transcription factors and human CTNNAL1 expression subsequent to ASO treatment. (A) (B) The mRNA
expression levels of LEF-1 and AP-2ain ozone-stressed HBEC were assessed by real-time PCR with and without ASO treatment. (C) Human CTNNAL1
mRNA expression was significantly induced by ozone exposure. The inducible expression was substantially reduced after ASO treatment specifically
targeting LEF-1 and AP-2a. Results are means6S.D. for four experiments. *P,0.05 compared with resting BEC group; #P,0.05 compared with
ozone-stressed BEC group without ASO treatment.
doi:10.1371/journal.pone.0031158.g007
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transcription factor have been described in numerous gene
promoters [23]. The expression of AP-2a is associated with the
embryonic differentiation and cancer [24,25]. Also, AP-2a has
been shown to regulate neuropeptide receptors [26,27] and
neuropeptide genes [28]. However, the activation and transloca-
tion of AP-2a remained unclear.
LEF-1 and AP-2a are transcription factors closely linked to cell
growth, differentiation and apoptosis. Our data showed that LEF-
1 and AP-2a can regulate the expression of CTNNAL1, suggesting
CTNNAL1 may play a role in cell growth and wound repair. In
the present study, we observed that the ozone-inducible LEF-1
and AP-2a activation and the expression of CTNNAL1 mRNA
was consistent with their activation, indicating that LEF-1 and AP-
2a jointly regulate the expression of CTNNAL in response to
ozone. However, how the early signals are transmitted to LEF-1
and AP-2a and how the early signal molecules assemble with these
two facts in response to ozone require further studies.
Overall, these observations encourage our next step of
investigation on the presence of these two transcription factor
binding site mutation in asthma patients, searching for new
molecular evidence of asthma susceptibility.
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